Reimer R, Odes H S, Beil W, Schwenk M, Muallem R, Sewing K F
Institute of General Pharmacology, Medical School, Hannover, Germany.
Pharmacology. 1996 Jun;52(6):339-46. doi: 10.1159/000139400.
To get information about the peptide hormone receptors involved in duodenal bicarbonate secretion (DBS) and their cellular location, we determined DBS and adenylate cyclase (AC) activity in response to hormones of the vasoactive intestinal polypeptide (VIP)/secretin family of peptides. DBS was determined in an isolated, perfused (24 mmol/1 NaHCO3) loop of the proximal duodenum in urethane- and indometacin-treated guinea pigs. AC stimulation was measured in isolated, homogenized duodenal enterocytes, the histological evaluation of which revealed their villous origin. VIP (10(-9) to 10(-7) mol x kg-1) dose-dependently increased DBS 3.5-fold (p < 0.01); this effect was completely inhibited by the VIP antagonist [D-p-Cl-Phe6,Leu17]VIP (10(-6) mol x kg-1). Glucagon (10(-8) to 10(-6) mol x kg-1) increased DBS 2.1-fold, while secretin (10(-9) to 10(-6) mol x kg-1) had no effect on DBS, but stimulated pancreatic bicarbonate secretion. VIP concentration-dependently increased AC activity 5.6-fold with an EC50 of 1.3 x 10(-9) mol/l. [D-p-Cl-Phe6,Leu17]VIP caused a rightward shift of the VIP concentration-response curve. A Schild plot analysis yielded a slope of 0.85 +/- 0.11, indicating competitive inhibition. While secretin also stimulated AC activity, although 1,000-fold less potent than VIP, glucagon was ineffective. These data indicate that specific VIP receptors, which mediate VIP-stimulated bicarbonate secretion, are present on villous enterocytes. Stimulation of AC by secretin seems to be of pharmacological relevance only and is consistent with the lack of effect of this hormone on DBS. Glucagon likely activates a second transmitter of bicarbonate secretion, or works independently of AC.
为获取有关十二指肠碳酸氢盐分泌(DBS)中涉及的肽激素受体及其细胞定位的信息,我们测定了对血管活性肠多肽(VIP)/促胰液素肽家族激素作出反应时的DBS和腺苷酸环化酶(AC)活性。在经氨基甲酸乙酯和吲哚美辛处理的豚鼠的近端十二指肠的分离灌注(24 mmol/1 NaHCO3)肠袢中测定DBS。在分离的、匀浆的十二指肠肠上皮细胞中测量AC刺激,其组织学评估显示它们起源于绒毛。VIP(10^(-9)至10^(-7) mol·kg^(-1))剂量依赖性地使DBS增加3.5倍(p < 0.01);这种作用被VIP拮抗剂[D-p-Cl-Phe6,Leu17]VIP(10^(-6) mol·kg^(-1))完全抑制。胰高血糖素(10^(-8)至10^(-6) mol·kg^(-1))使DBS增加2.1倍,而促胰液素(10^(-9)至10^(-6) mol·kg^(-1))对DBS无影响,但刺激胰腺碳酸氢盐分泌。VIP浓度依赖性地使AC活性增加5.6倍,EC50为1.3×10^(-9) mol/l。[D-p-Cl-Phe6,Leu17]VIP使VIP浓度-反应曲线向右移动。Schild图分析得出斜率为0.85±0.11,表明为竞争性抑制。虽然促胰液素也刺激AC活性,但其效力比VIP低1000倍,胰高血糖素则无效。这些数据表明,介导VIP刺激的碳酸氢盐分泌的特异性VIP受体存在于绒毛肠上皮细胞上。促胰液素对AC的刺激似乎仅具有药理学相关性,并且与该激素对DBS缺乏作用一致。胰高血糖素可能激活碳酸氢盐分泌的第二种递质,或独立于AC起作用。